1988
Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminum hydroxide therapy
Search citation statements
Paper Sections
Select...
16
3
1
0
Citation Types
0
11
0
1
Year Published
1994
2021
Publication Types
Select...
18
2
Relationship
0
20
Authors
Journals
Cited by 20 publications
(12 citation statements)
References 0 publications
0
11
0
1
“…Reports have been published concerning the treatment of calcinosis with colchicine, probenecid [ 6 , 7 ], aluminium hydroxide [ 8 ], diltiazem [ 9 , 10 ], high-dose immunoglobulin therapy [ 11 ], bisphosphonate preparations, and anti-TNF α preparations [ 12 ], but there is still no established regimen for this condition.…”
Section: Discussionmentioning
confidence: 99%
“…Reports have been published concerning the treatment of calcinosis with colchicine, probenecid [ 6 , 7 ], aluminium hydroxide [ 8 ], diltiazem [ 9 , 10 ], high-dose immunoglobulin therapy [ 11 ], bisphosphonate preparations, and anti-TNF α preparations [ 12 ], but there is still no established regimen for this condition.…”
Section: Discussionmentioning
confidence: 99%
“…La pathogénie de cette affection n'est toujours pas complètement identifiée. Bien que la calcinose ne soit pas rare dans les maladies du tissu conjonctif comme la sclérodermie et la dermatomyosite, aucun essai théra- Différentes spécialités ont été utilisées dans le traitement de la calcinose : colchicine, probénécide [2,3], hydroxyde d'aluminium [4], diltiazem [5,6], immunoglobulines intraveineuses [7], biphosphonates [6,8,9] et agents anti-TNF alpha [10]. Leur efficacité est inconstante, mais aucune conclusion ne peut en être tirée en raison du peu de patients traités et de l'évolution naturelle imprévisible de la calcinose dont la rémission spontanée est possible.…”
Section: Discussionunclassified
“…Furthermore, excessive dosages can lead to the development of osteomalacia and fractures (5). Aluminum hydroxide, an oral phosphatebinding agent, has been reported to be an effective compound for treating the calcinosis of dermatomyositis (13).…”
Section: Discussionmentioning
confidence: 99%
